ExploreWatchlistsPricing
  1. JP-listed companies
  2. OLYMPUS CORPORATION
  3. Financials
  4. Pretax margin (%)

OLYMPUS CORPORATION (7733)

Market cap
¥2.02T
P/E ratio
21x
Olympus manufactures medical endoscopes and therapeutic devices for hospitals and healthcare providers worldwide, specializing in gastrointestinal, surgical, and diagnostic equipment.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 20267.6-52.11%
Mar 31, 202515.9+316.47%
Mar 31, 20243.8-81.47%
Mar 31, 202320.7+19.83%
Mar 31, 202217.2+64.06%
Mar 31, 202110.5+7.77%
Mar 31, 20209.8+285.01%
Mar 31, 20192.5-73.92%
Mar 31, 20189.7+16.96%
Mar 31, 20178.3-26.46%
Mar 31, 201611.3+18.70%
Mar 31, 20159.5+33.35%
Mar 31, 20147.1+306.98%
Mar 31, 20131.8-16.70%
Mar 31, 20122.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat